Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Somatostatin receptor subtype 4 (SSTR4) is a G protein-coupled receptor that binds somatostatin. SSTR4 mediates analgesic, anti-inflammatory, and antidepressant effects without significant endocrine actions. It is expressed in the brain, lung, and other tissues and plays a role in learning, memory, and amyloid beta-peptide degradation. SSTR4 is a potential therapeutic target for chronic pain, neurodegenerative diseases, epilepsy, and depression.
Gi/o-mediated inhibition of adenylyl cyclase/cAMP pathway; modulation of MAPK cascade; modulation of neuronal excitability; induction of G1 cell cycle arrest; promotion or inhibition of apoptosis
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Somatostatin Receptor Subtype 4 (SSTR4).